BioGrowing, a probiotics comprehensive solutions provider focused on the research, development, production, and sales of probiotics, is proud to announce its participation in Pharmtech & Ingredients 2025, taking place from November 25 to 28 at Crocus Expo, Pavilion 2. The company invites industry professionals to visit Booth #B1041 at Pavilion 2.7 to explore its latest advancements in probiotic research and application, including the groundbreaking new Akkermansia products. 

 

Akkermansia muciniphila is a next-generation probiotic strain demonstrating exceptional potential in gut health innovation. The company's innovative approach features both the live strain AKK WST01 and the inactivated strain AKKBG-001^TM, designed to address the global metabolic health crisis exacerbated by obesity and diabetes. 

AKK WST01, a clinically validated live strain, has demonstrated remarkable efficacy in a 12-week randomized, double-blind, placebo-controlled trial involving overweight/obese type 2 diabetics, showing significant reductions in body weight, BMI, HbA1c, visceral fat mass, and LDL-C, etc., while enhancing insulin sensitivity and fat oxidation rates, with its research published in top-tier journal Cell Metabolism and achieving Self-GRAS status. 


 

AKKBG-001^TM is an inactivated strain sourced from healthy human intestines in Kashgar, Xinjiang, produced by BioGrowing’s proprietary anaerobic fermentation and high-fidelity inactivation. Its heat-killed form enables broad application in various product formats while BioGrowing will present the 300-billion-TFU, high-purity AKKBG-001^TM capsule products at the booth. 

Another noteworthy product is the deep-frozen BioGuard® Starter Cultures, guaranteed by the unique “Premium Starter Cultures Diamond-Level 6 Dimensions” standard, which encompasses fermentation activity, post-acidification, texture, aroma, sensory profile, and anti-phage performance to ensure consistent fermentation quality while meeting customers’ specific requirements for texture and taste.

BioGrowing will also showcase its solutions for targeted health scenarios through its flagship Flora-Focus® probiotics, addressing nine health domains including gut health, oral health, immune modulation, and more.


 

BioGrowing has been recognised by Lumina Intelligence as one of the top three immune probiotic suppliers and one of the top five digestive probiotic suppliers. With over 20 years of specialised experience and exports to more than 80 countries and regions, the company’s market leadership is supported by an in-house culture collection of over 50,000 strains, a testament to its scientific legacy and commitment to microbial research and development.

“We’re excited to share these developments with the global health community and explore new partnership opportunities that can bring innovative solutions to market,” a company representative noted.

 

Visitors to the booth are welcome to engage with technical experts to discuss custom formulation requirements and explore opportunities for deeper collaboration and knowledge exchange, driving industry development and innovation together.

About BioGrowing Probiotics

BioGrowing Co., Ltd. is a comprehensive probiotics solution provider focused on research, development, production, and sales. As one of the largest probiotic production bases in Asia, the company offers a diverse product range including probiotic powders, starter cultures, functional foods, and derivative products, widely used across food, pharmaceuticals and healthcare, daily chemicals, aquaculture, and other sectors. Guided by the core value “BioGrowing, Reliable for a Better World”, the company is dedicated to advancing probiotic research, development, and innovation. BioGrowing continues to progress towards its vision of becoming a “global leading probiotics manufacturer”, delivering a complete suite of product solutions and high-quality services to its customers.

Media Contact

Email: cs@biogrowing.com
Website: www.biogrowing.com